To evaluate the feasibility of the autoinflammatory disease activity index (AIDAI) as a tool to assess disease activity in patients with hereditary recurrent fever syndromes (HRFs) treated with canakinumab.
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab / Koné-Paut, Isabelle; Piram, Maryam; Benseler, Susanne; Kuemmerle-Deschner, Jasmin B; Jansson, Annette; Rosner, Itzhak; Tommasini, Alberto; Murias, Sara; Karadag, Omer; Levy, Jeremy; Mccreddin, Suzanne; Migliaccio, Marco; Benedetti, Fabrizio De. - In: JOINT BONE SPINE. - ISSN 1297-319X. - 89:6(2022), pp. 105448."-"-105448."-". [10.1016/j.jbspin.2022.105448]
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab
Tommasini, Alberto;
2022-01-01
Abstract
To evaluate the feasibility of the autoinflammatory disease activity index (AIDAI) as a tool to assess disease activity in patients with hereditary recurrent fever syndromes (HRFs) treated with canakinumab.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1297319X22001087-main.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
1.5 MB
Formato
Adobe PDF
|
1.5 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
